ADIPOQ and Insulin resistance: Shimada et al. reported that approximately 90% of the patients with early-stage NASH can be predicted by a combined evaluation of the serum adiponectin level, homeostasis model assessment of insulin resistance (HOMA-IR), and serum type IV collagen 7S level [54].